Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Levonorgestrel 0.75 mg vs POSTINOR in healthy Thai female volunteers
TCTR20220601001Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of avatrombopag in None (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
avatrombopag
Beyond the preview
Go deeper on TCTR20220601001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220601001.